International Braz J Urol ::
PSA Doubling Time Calculator
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Roundtable Discussion: Morgans Addresses How PSA Levels Affect Nonmetastatic CRPC Treatment
International Braz J Urol ::
Prostatic Specific Antigen for Prostate Cancer Detection
Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy | HTML
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time | American Society of Clinical Oncology Educational Book
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - The Lancet Oncology
Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinations - Urology
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the place
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Abiraterone Acetate for Adenocarcinoma Clinical Trial 2022 | Power
The PSA-doubling time in patients with different rate of prostate... | Download Table
Cureus | Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
